NEXALIN TECHNOLOGY INC (NXL) Fundamental Analysis & Valuation
NASDAQ:NXL • US65345B2016
0.4273 USD
-0.01 (-1.27%)
Last: Mar 11, 2026, 04:30 PM
This NXL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
Overall NXL gets a fundamental rating of 3 out of 10. We evaluated NXL against 184 industry peers in the Health Care Equipment & Supplies industry. NXL has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, NXL is valued expensive at the moment.
1. NXL Profitability Analysis
1.1 Basic Checks
- NXL had negative earnings in the past year.
- In the past year NXL has reported a negative cash flow from operations.
- NXL had negative earnings in each of the past 5 years.
- NXL had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- NXL's Return On Assets of -169.31% is on the low side compared to the rest of the industry. NXL is outperformed by 89.13% of its industry peers.
- NXL has a worse Return On Equity (-182.01%) than 72.28% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -169.31% | ||
| ROE | -182.01% | ||
| ROIC | N/A |
ROA(3y)-110.33%
ROA(5y)-801.91%
ROE(3y)-127.63%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- NXL has a better Gross Margin (69.55%) than 77.72% of its industry peers.
- NXL's Gross Margin has improved in the last couple of years.
- NXL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 69.55% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.73%
GM growth 5Y2.21%
2. NXL Health Analysis
2.1 Basic Checks
- NXL does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, NXL has more shares outstanding
- Compared to 5 years ago, NXL has more shares outstanding
- There is no outstanding debt for NXL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- Based on the Altman-Z score of -15.79, we must say that NXL is in the distress zone and has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of -15.79, NXL is doing worse than 86.96% of the companies in the same industry.
- There is no outstanding debt for NXL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -15.79 |
ROIC/WACCN/A
WACC9.87%
2.3 Liquidity
- A Current Ratio of 13.48 indicates that NXL has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 13.48, NXL belongs to the top of the industry, outperforming 98.37% of the companies in the same industry.
- A Quick Ratio of 13.03 indicates that NXL has no problem at all paying its short term obligations.
- With an excellent Quick ratio value of 13.03, NXL belongs to the best of the industry, outperforming 97.83% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 13.48 | ||
| Quick Ratio | 13.03 |
3. NXL Growth Analysis
3.1 Past
- The Earnings Per Share has been growing slightly by 0.33% over the past year.
- The Revenue has decreased by -3.09% in the past year.
- The Revenue has been decreasing by -4.05% on average over the past years.
EPS 1Y (TTM)0.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.48%
Revenue 1Y (TTM)-3.09%
Revenue growth 3Y5.39%
Revenue growth 5Y-4.05%
Sales Q2Q%-49.58%
3.2 Future
- NXL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.65% yearly.
- Based on estimates for the next years, NXL will show a very strong growth in Revenue. The Revenue will grow by 95.89% on average per year.
EPS Next Y19.67%
EPS Next 2Y16.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year34.3%
Revenue Next 2Y95.89%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. NXL Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for NXL. In the last year negative earnings were reported.
- Also next year NXL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as NXL's earnings are expected to grow with 16.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.65%
EPS Next 3YN/A
5. NXL Dividend Analysis
5.1 Amount
- NXL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NXL Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:NXL (3/11/2026, 4:30:02 PM)
0.4273
-0.01 (-1.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-14 2025-11-14/dmh
Earnings (Next)03-12 2026-03-12
Inst Owners6.62%
Inst Owner Change74.75%
Ins Owners12.78%
Ins Owner Change5.82%
Market Cap7.97M
Revenue(TTM)157.00K
Net Income(TTM)-8.68M
Analysts80
Price Target4.08 (854.83%)
Short Float %3.54%
Short Ratio1.49
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)11.01%
Min EPS beat(2)-7.26%
Max EPS beat(2)29.28%
EPS beat(4)1
Avg EPS beat(4)-39.38%
Min EPS beat(4)-131.02%
Max EPS beat(4)29.28%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)21.47%
Min Revenue beat(2)-55.07%
Max Revenue beat(2)98.02%
Revenue beat(4)2
Avg Revenue beat(4)12.01%
Min Revenue beat(4)-55.07%
Max Revenue beat(4)98.02%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 50.76 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.67 | ||
| P/tB | 1.79 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.66
EYN/A
EPS(NY)-0.39
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS0.01
BVpS0.26
TBVpS0.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -169.31% | ||
| ROE | -182.01% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 69.55% | ||
| FCFM | N/A |
ROA(3y)-110.33%
ROA(5y)-801.91%
ROE(3y)-127.63%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.73%
GM growth 5Y2.21%
F-Score2
Asset Turnover0.03
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 92.42% | ||
| Cap/Sales | 11.66% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 13.48 | ||
| Quick Ratio | 13.03 | ||
| Altman-Z | -15.79 |
F-Score2
WACC9.87%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.48%
EPS Next Y19.67%
EPS Next 2Y16.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.09%
Revenue growth 3Y5.39%
Revenue growth 5Y-4.05%
Sales Q2Q%-49.58%
Revenue Next Year34.3%
Revenue Next 2Y95.89%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-32.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-32.27%
OCF growth 3YN/A
OCF growth 5YN/A
NEXALIN TECHNOLOGY INC / NXL FAQ
Can you provide the ChartMill fundamental rating for NEXALIN TECHNOLOGY INC?
ChartMill assigns a fundamental rating of 3 / 10 to NXL.
Can you provide the valuation status for NEXALIN TECHNOLOGY INC?
ChartMill assigns a valuation rating of 0 / 10 to NEXALIN TECHNOLOGY INC (NXL). This can be considered as Overvalued.
How profitable is NEXALIN TECHNOLOGY INC (NXL) stock?
NEXALIN TECHNOLOGY INC (NXL) has a profitability rating of 1 / 10.
Can you provide the expected EPS growth for NXL stock?
The Earnings per Share (EPS) of NEXALIN TECHNOLOGY INC (NXL) is expected to grow by 19.67% in the next year.